Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Aspirin	1,163
Overall Study	STARTED	Warfarin	1,142
Overall Study	Completed Follow-up	Aspirin	761
Overall Study	Completed Follow-up	Warfarin	745
Overall Study	Primary Endpoint	Aspirin	320
Overall Study	Primary Endpoint	Warfarin	302
Overall Study	Only Vital Status Known	Aspirin	44
Overall Study	Only Vital Status Known	Warfarin	46
Overall Study	Lost to Follow-up	Aspirin	18
Overall Study	Lost to Follow-up	Warfarin	17
Overall Study	Withdrew Consent	Aspirin	20
Overall Study	Withdrew Consent	Warfarin	14
Overall Study	COMPLETED	Aspirin	1,125
Overall Study	COMPLETED	Warfarin	1,111
Overall Study	NOT COMPLETED	Aspirin	38
Overall Study	NOT COMPLETED	Warfarin	31

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00041938/flow